Therapeutics News

Acetaminophen and ibuprofen may manage postoperative pain after dermatologic surgery while avoiding opioid exposure, according to a presentation at the American Society for Dermatologic Surgery annual meeting.

Meditation and mindfulness techniques may improve patients’ perspectives on their skin disease, according to a poster presented at the American Academy of Dermatology virtual meeting.

Adding lidocaine to intralesional corticosteroid injections caused more pain compared with corticosteroid injections mixed with saline, according to a poster presented at the American Academy of Dermatology virtual meeting.

Steroid phobia can be reduced with targeted education, but adherence to medication protocols was not significantly affected, according to a study poster presented at the American Academy of Dermatology virtual meeting.

Biologic therapies have been proven to significantly change treatment ability and improve the condition of patients with hidradenitis suppurativa, according to a presentation at the Interdisciplinary Autoimmune Summit.

Once-daily use of ruxolitinib cream may have a greater rate of repigmentation in patients with vitiligo, according to findings presented at the American Academy of Dermatology virtual meeting.

Enrollment is underway in the 2b portion of a phase 1/2b trial of ARQ-252 for the treatment of chronic hand eczema, Arcutis Biotherapeutics announced in a press release.

The FDA has approved Qwo for the treatment of moderate to severe cellulite in the buttocks of adult women, Endo International announced in a press release.

Sofpironium bromide gel reduced hyperhidrosis with few adverse events in Japanese patients, according to findings from a phase 3 study presented at the American Academy of Dermatology virtual meeting.

A topical minocycline foam was safe and well tolerated for long-term papulopustular rosacea treatment, according to study findings presented at the American Academy of Dermatology virtual meeting.